nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP2—breast cancer	0.21	0.442	CbGaD
Captopril—MMP9—breast cancer	0.138	0.291	CbGaD
Captopril—CYP2D6—breast cancer	0.0513	0.108	CbGaD
Captopril—ALB—breast cancer	0.0384	0.0809	CbGaD
Captopril—ABCB1—breast cancer	0.0366	0.0772	CbGaD
Captopril—ABCB1—Toremifene—breast cancer	0.0235	0.124	CbGbCtD
Captopril—CYP2D6—Idarubicin—breast cancer	0.0184	0.097	CbGbCtD
Captopril—ABCB1—Lapatinib—breast cancer	0.0172	0.0907	CbGbCtD
Captopril—ALB—Irinotecan—breast cancer	0.0126	0.0666	CbGbCtD
Captopril—ALB—Fluorouracil—breast cancer	0.0121	0.064	CbGbCtD
Captopril—ABCB1—Vinorelbine—breast cancer	0.00952	0.0503	CbGbCtD
Captopril—CYP2D6—Vinorelbine—breast cancer	0.00897	0.0474	CbGbCtD
Captopril—ABCB1—Tamoxifen—breast cancer	0.0086	0.0454	CbGbCtD
Captopril—ABCB1—Mitoxantrone—breast cancer	0.00839	0.0443	CbGbCtD
Captopril—CYP2D6—Tamoxifen—breast cancer	0.0081	0.0428	CbGbCtD
Captopril—SLC22A6—Methotrexate—breast cancer	0.00784	0.0414	CbGbCtD
Captopril—ABCB1—Gemcitabine—breast cancer	0.00741	0.0391	CbGbCtD
Captopril—ABCB1—Paclitaxel—breast cancer	0.00669	0.0353	CbGbCtD
Captopril—ALB—Methotrexate—breast cancer	0.00668	0.0353	CbGbCtD
Captopril—ABCB1—Irinotecan—breast cancer	0.0066	0.0349	CbGbCtD
Captopril—ABCB1—Vinblastine—breast cancer	0.00587	0.031	CbGbCtD
Captopril—CYP2D6—Vinblastine—breast cancer	0.00553	0.0292	CbGbCtD
Captopril—ABCB1—Docetaxel—breast cancer	0.00484	0.0255	CbGbCtD
Captopril—REN—arm—breast cancer	0.00445	0.0674	CbGeAlD
Captopril—ABCB1—Doxorubicin—breast cancer	0.00361	0.019	CbGbCtD
Captopril—ABCB1—Methotrexate—breast cancer	0.00349	0.0185	CbGbCtD
Captopril—CYP2D6—Doxorubicin—breast cancer	0.0034	0.0179	CbGbCtD
Captopril—LTA4H—mammary gland—breast cancer	0.00252	0.0382	CbGeAlD
Captopril—ACE—umbilical vein—breast cancer	0.00217	0.0329	CbGeAlD
Captopril—LTA4H—nipple—breast cancer	0.00209	0.0316	CbGeAlD
Captopril—MMP2—Estradiol—Fulvestrant—breast cancer	0.002	0.778	CbGdCrCtD
Captopril—ACE—arm—breast cancer	0.0019	0.0287	CbGeAlD
Captopril—MMP2—mammary gland—breast cancer	0.00179	0.0271	CbGeAlD
Captopril—LTA4H—embryo—breast cancer	0.00172	0.0261	CbGeAlD
Captopril—MMP2—nipple—breast cancer	0.00148	0.0224	CbGeAlD
Captopril—F2—mammary gland—breast cancer	0.00136	0.0206	CbGeAlD
Captopril—LTA4H—endometrium—breast cancer	0.00126	0.0191	CbGeAlD
Captopril—MMP2—embryo—breast cancer	0.00122	0.0185	CbGeAlD
Captopril—LTA4H—uterus—breast cancer	0.00116	0.0176	CbGeAlD
Captopril—LTA4H—pituitary gland—breast cancer	0.00114	0.0173	CbGeAlD
Captopril—LTA4H—adipose tissue—breast cancer	0.00114	0.0172	CbGeAlD
Captopril—REN—epithelium—breast cancer	0.00108	0.0164	CbGeAlD
Captopril—MMP9—embryo—breast cancer	0.00106	0.0161	CbGeAlD
Captopril—LTA4H—female reproductive system—breast cancer	0.00104	0.0158	CbGeAlD
Captopril—LTA4H—adrenal gland—breast cancer	0.00102	0.0154	CbGeAlD
Captopril—MMP2—epithelium—breast cancer	0.000997	0.0151	CbGeAlD
Captopril—LTA4H—bone marrow—breast cancer	0.000985	0.0149	CbGeAlD
Captopril—REN—endometrium—breast cancer	0.000972	0.0147	CbGeAlD
Captopril—LTA4H—female gonad—breast cancer	0.000949	0.0144	CbGeAlD
Captopril—MMP2—skin of body—breast cancer	0.000948	0.0143	CbGeAlD
Captopril—MMP2—endometrium—breast cancer	0.000894	0.0135	CbGeAlD
Captopril—LTA4H—endocrine gland—breast cancer	0.000883	0.0134	CbGeAlD
Captopril—REN—pituitary gland—breast cancer	0.00088	0.0133	CbGeAlD
Captopril—MMP9—epithelium—breast cancer	0.000867	0.0131	CbGeAlD
Captopril—ALB—mammary gland—breast cancer	0.000867	0.0131	CbGeAlD
Captopril—MMP9—skin of body—breast cancer	0.000824	0.0125	CbGeAlD
Captopril—MMP2—uterus—breast cancer	0.000823	0.0125	CbGeAlD
Captopril—MMP2—pituitary gland—breast cancer	0.000809	0.0122	CbGeAlD
Captopril—MMP2—adipose tissue—breast cancer	0.000805	0.0122	CbGeAlD
Captopril—REN—female reproductive system—breast cancer	0.000805	0.0122	CbGeAlD
Captopril—REN—adrenal gland—breast cancer	0.000786	0.0119	CbGeAlD
Captopril—MMP9—endometrium—breast cancer	0.000777	0.0118	CbGeAlD
Captopril—F2—epithelium—breast cancer	0.000756	0.0114	CbGeAlD
Captopril—MMP2—female reproductive system—breast cancer	0.00074	0.0112	CbGeAlD
Captopril—REN—female gonad—breast cancer	0.000733	0.0111	CbGeAlD
Captopril—MMP2—adrenal gland—breast cancer	0.000722	0.0109	CbGeAlD
Captopril—MMP9—uterus—breast cancer	0.000716	0.0108	CbGeAlD
Captopril—MMP9—adipose tissue—breast cancer	0.0007	0.0106	CbGeAlD
Captopril—REN—endocrine gland—breast cancer	0.000681	0.0103	CbGeAlD
Captopril—MMP2—female gonad—breast cancer	0.000674	0.0102	CbGeAlD
Captopril—SLC15A1—epithelium—breast cancer	0.000644	0.00975	CbGeAlD
Captopril—MMP9—female reproductive system—breast cancer	0.000644	0.00975	CbGeAlD
Captopril—MMP9—adrenal gland—breast cancer	0.000628	0.00951	CbGeAlD
Captopril—MMP2—endocrine gland—breast cancer	0.000626	0.00948	CbGeAlD
Captopril—LTA4H—lymph node—breast cancer	0.00061	0.00924	CbGeAlD
Captopril—MMP9—bone marrow—breast cancer	0.000608	0.0092	CbGeAlD
Captopril—MMP9—female gonad—breast cancer	0.000586	0.00887	CbGeAlD
Captopril—SLC15A1—endometrium—breast cancer	0.000578	0.00875	CbGeAlD
Captopril—ACE—embryo—breast cancer	0.000566	0.00857	CbGeAlD
Captopril—F2—female reproductive system—breast cancer	0.000562	0.0085	CbGeAlD
Captopril—F2—adrenal gland—breast cancer	0.000548	0.0083	CbGeAlD
Captopril—MMP9—endocrine gland—breast cancer	0.000545	0.00825	CbGeAlD
Captopril—F2—bone marrow—breast cancer	0.00053	0.00803	CbGeAlD
Captopril—F2—female gonad—breast cancer	0.000511	0.00774	CbGeAlD
Captopril—F2—endocrine gland—breast cancer	0.000475	0.0072	CbGeAlD
Captopril—ACE—epithelium—breast cancer	0.000462	0.00699	CbGeAlD
Captopril—MMP2—lymph node—breast cancer	0.000433	0.00656	CbGeAlD
Captopril—ACE—endometrium—breast cancer	0.000414	0.00627	CbGeAlD
Captopril—SLC15A1—endocrine gland—breast cancer	0.000405	0.00613	CbGeAlD
Captopril—MMP9—lymph node—breast cancer	0.000377	0.0057	CbGeAlD
Captopril—ACE—pituitary gland—breast cancer	0.000375	0.00567	CbGeAlD
Captopril—ACE—adipose tissue—breast cancer	0.000373	0.00565	CbGeAlD
Captopril—ALB—adrenal gland—breast cancer	0.00035	0.0053	CbGeAlD
Captopril—ACE—female reproductive system—breast cancer	0.000343	0.00519	CbGeAlD
Captopril—ACE—adrenal gland—breast cancer	0.000335	0.00507	CbGeAlD
Captopril—ACE—bone marrow—breast cancer	0.000324	0.0049	CbGeAlD
Captopril—ACE—female gonad—breast cancer	0.000312	0.00473	CbGeAlD
Captopril—ACE—endocrine gland—breast cancer	0.00029	0.0044	CbGeAlD
Captopril—MMP2—Dexamethasone—Fluoxymesterone—breast cancer	0.000286	0.111	CbGdCrCtD
Captopril—MMP2—Betamethasone—Fluoxymesterone—breast cancer	0.000286	0.111	CbGdCrCtD
Captopril—ALB—lymph node—breast cancer	0.00021	0.00317	CbGeAlD
Captopril—ACE—lymph node—breast cancer	0.000201	0.00304	CbGeAlD
Captopril—ABCB1—embryo—breast cancer	0.000199	0.00302	CbGeAlD
Captopril—CYP2D6—female reproductive system—breast cancer	0.000168	0.00254	CbGeAlD
Captopril—ABCB1—epithelium—breast cancer	0.000163	0.00246	CbGeAlD
Captopril—CYP2D6—female gonad—breast cancer	0.000153	0.00231	CbGeAlD
Captopril—ABCB1—endometrium—breast cancer	0.000146	0.00221	CbGeAlD
Captopril—CYP2D6—endocrine gland—breast cancer	0.000142	0.00215	CbGeAlD
Captopril—ABCB1—uterus—breast cancer	0.000134	0.00203	CbGeAlD
Captopril—ABCB1—pituitary gland—breast cancer	0.000132	0.002	CbGeAlD
Captopril—ABCB1—adipose tissue—breast cancer	0.000131	0.00199	CbGeAlD
Captopril—ABCB1—female reproductive system—breast cancer	0.000121	0.00183	CbGeAlD
Captopril—ABCB1—adrenal gland—breast cancer	0.000118	0.00178	CbGeAlD
Captopril—ABCB1—bone marrow—breast cancer	0.000114	0.00173	CbGeAlD
Captopril—ABCB1—female gonad—breast cancer	0.00011	0.00166	CbGeAlD
Captopril—Enalapril—CYP3A4—breast cancer	0.000108	0.546	CrCbGaD
Captopril—ABCB1—endocrine gland—breast cancer	0.000102	0.00155	CbGeAlD
Captopril—Enalapril—ABCB1—breast cancer	8.99e-05	0.454	CrCbGaD
Captopril—ABCB1—lymph node—breast cancer	7.07e-05	0.00107	CbGeAlD
Captopril—Constipation—Paclitaxel—breast cancer	4.42e-05	0.000319	CcSEcCtD
Captopril—Confusional state—Docetaxel—breast cancer	4.41e-05	0.000319	CcSEcCtD
Captopril—Pharyngitis—Methotrexate—breast cancer	4.41e-05	0.000318	CcSEcCtD
Captopril—Photosensitivity reaction—Doxorubicin—breast cancer	4.38e-05	0.000317	CcSEcCtD
Captopril—Anaphylactic shock—Docetaxel—breast cancer	4.38e-05	0.000316	CcSEcCtD
Captopril—Discomfort—Capecitabine—breast cancer	4.37e-05	0.000315	CcSEcCtD
Captopril—Pruritus—Gemcitabine—breast cancer	4.36e-05	0.000315	CcSEcCtD
Captopril—Nausea—Thiotepa—breast cancer	4.36e-05	0.000314	CcSEcCtD
Captopril—Weight decreased—Doxorubicin—breast cancer	4.35e-05	0.000314	CcSEcCtD
Captopril—Diarrhoea—Mitoxantrone—breast cancer	4.33e-05	0.000313	CcSEcCtD
Captopril—Diarrhoea—Irinotecan—breast cancer	4.33e-05	0.000313	CcSEcCtD
Captopril—Dry mouth—Capecitabine—breast cancer	4.32e-05	0.000312	CcSEcCtD
Captopril—Agranulocytosis—Epirubicin—breast cancer	4.32e-05	0.000312	CcSEcCtD
Captopril—Shock—Docetaxel—breast cancer	4.31e-05	0.000311	CcSEcCtD
Captopril—Pruritus—Fluorouracil—breast cancer	4.29e-05	0.00031	CcSEcCtD
Captopril—Thrombocytopenia—Docetaxel—breast cancer	4.29e-05	0.000309	CcSEcCtD
Captopril—Confusional state—Capecitabine—breast cancer	4.27e-05	0.000309	CcSEcCtD
Captopril—Tachycardia—Docetaxel—breast cancer	4.27e-05	0.000308	CcSEcCtD
Captopril—Feeling abnormal—Paclitaxel—breast cancer	4.26e-05	0.000307	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Doxorubicin—breast cancer	4.25e-05	0.000307	CcSEcCtD
Captopril—Gastrointestinal pain—Paclitaxel—breast cancer	4.22e-05	0.000305	CcSEcCtD
Captopril—Diarrhoea—Gemcitabine—breast cancer	4.22e-05	0.000305	CcSEcCtD
Captopril—Renal failure—Doxorubicin—breast cancer	4.21e-05	0.000304	CcSEcCtD
Captopril—Erythema multiforme—Methotrexate—breast cancer	4.2e-05	0.000303	CcSEcCtD
Captopril—Dizziness—Irinotecan—breast cancer	4.19e-05	0.000302	CcSEcCtD
Captopril—Jaundice—Doxorubicin—breast cancer	4.18e-05	0.000301	CcSEcCtD
Captopril—Stomatitis—Doxorubicin—breast cancer	4.18e-05	0.000301	CcSEcCtD
Captopril—Anorexia—Docetaxel—breast cancer	4.17e-05	0.000301	CcSEcCtD
Captopril—Shock—Capecitabine—breast cancer	4.17e-05	0.000301	CcSEcCtD
Captopril—Rhinitis—Epirubicin—breast cancer	4.17e-05	0.000301	CcSEcCtD
Captopril—Hepatitis—Epirubicin—breast cancer	4.16e-05	0.0003	CcSEcCtD
Captopril—Diarrhoea—Fluorouracil—breast cancer	4.15e-05	0.0003	CcSEcCtD
Captopril—Thrombocytopenia—Capecitabine—breast cancer	4.15e-05	0.0003	CcSEcCtD
Captopril—Tachycardia—Capecitabine—breast cancer	4.14e-05	0.000299	CcSEcCtD
Captopril—Pharyngitis—Epirubicin—breast cancer	4.12e-05	0.000298	CcSEcCtD
Captopril—Hypotension—Docetaxel—breast cancer	4.09e-05	0.000295	CcSEcCtD
Captopril—Abdominal pain—Paclitaxel—breast cancer	4.08e-05	0.000295	CcSEcCtD
Captopril—Body temperature increased—Paclitaxel—breast cancer	4.08e-05	0.000295	CcSEcCtD
Captopril—Anorexia—Capecitabine—breast cancer	4.04e-05	0.000292	CcSEcCtD
Captopril—Vomiting—Irinotecan—breast cancer	4.03e-05	0.000291	CcSEcCtD
Captopril—Vomiting—Mitoxantrone—breast cancer	4.03e-05	0.000291	CcSEcCtD
Captopril—Dizziness—Fluorouracil—breast cancer	4.01e-05	0.00029	CcSEcCtD
Captopril—Agranulocytosis—Doxorubicin—breast cancer	4e-05	0.000289	CcSEcCtD
Captopril—Rash—Mitoxantrone—breast cancer	3.99e-05	0.000288	CcSEcCtD
Captopril—Rash—Irinotecan—breast cancer	3.99e-05	0.000288	CcSEcCtD
Captopril—Dermatitis—Mitoxantrone—breast cancer	3.99e-05	0.000288	CcSEcCtD
Captopril—Dermatitis—Irinotecan—breast cancer	3.99e-05	0.000288	CcSEcCtD
Captopril—Musculoskeletal discomfort—Docetaxel—breast cancer	3.99e-05	0.000288	CcSEcCtD
Captopril—Headache—Mitoxantrone—breast cancer	3.97e-05	0.000286	CcSEcCtD
Captopril—Headache—Irinotecan—breast cancer	3.97e-05	0.000286	CcSEcCtD
Captopril—Hypotension—Capecitabine—breast cancer	3.96e-05	0.000286	CcSEcCtD
Captopril—Insomnia—Docetaxel—breast cancer	3.96e-05	0.000286	CcSEcCtD
Captopril—Paraesthesia—Docetaxel—breast cancer	3.93e-05	0.000284	CcSEcCtD
Captopril—Erythema multiforme—Epirubicin—breast cancer	3.93e-05	0.000284	CcSEcCtD
Captopril—Alopecia—Methotrexate—breast cancer	3.92e-05	0.000283	CcSEcCtD
Captopril—Vomiting—Gemcitabine—breast cancer	3.92e-05	0.000283	CcSEcCtD
Captopril—Dyspnoea—Docetaxel—breast cancer	3.9e-05	0.000282	CcSEcCtD
Captopril—Somnolence—Docetaxel—breast cancer	3.89e-05	0.000281	CcSEcCtD
Captopril—Rash—Gemcitabine—breast cancer	3.89e-05	0.000281	CcSEcCtD
Captopril—Dermatitis—Gemcitabine—breast cancer	3.89e-05	0.000281	CcSEcCtD
Captopril—Headache—Gemcitabine—breast cancer	3.86e-05	0.000279	CcSEcCtD
Captopril—Musculoskeletal discomfort—Capecitabine—breast cancer	3.86e-05	0.000279	CcSEcCtD
Captopril—Flushing—Epirubicin—breast cancer	3.86e-05	0.000278	CcSEcCtD
Captopril—Vomiting—Fluorouracil—breast cancer	3.86e-05	0.000278	CcSEcCtD
Captopril—Rhinitis—Doxorubicin—breast cancer	3.85e-05	0.000278	CcSEcCtD
Captopril—Dyspepsia—Docetaxel—breast cancer	3.85e-05	0.000278	CcSEcCtD
Captopril—Hepatitis—Doxorubicin—breast cancer	3.85e-05	0.000278	CcSEcCtD
Captopril—Insomnia—Capecitabine—breast cancer	3.83e-05	0.000277	CcSEcCtD
Captopril—Rash—Fluorouracil—breast cancer	3.82e-05	0.000276	CcSEcCtD
Captopril—Dermatitis—Fluorouracil—breast cancer	3.82e-05	0.000276	CcSEcCtD
Captopril—Pharyngitis—Doxorubicin—breast cancer	3.82e-05	0.000276	CcSEcCtD
Captopril—Paraesthesia—Capecitabine—breast cancer	3.81e-05	0.000275	CcSEcCtD
Captopril—Decreased appetite—Docetaxel—breast cancer	3.81e-05	0.000275	CcSEcCtD
Captopril—Headache—Fluorouracil—breast cancer	3.8e-05	0.000274	CcSEcCtD
Captopril—Dysgeusia—Methotrexate—breast cancer	3.79e-05	0.000273	CcSEcCtD
Captopril—Dyspnoea—Capecitabine—breast cancer	3.78e-05	0.000273	CcSEcCtD
Captopril—Fatigue—Docetaxel—breast cancer	3.77e-05	0.000272	CcSEcCtD
Captopril—Nausea—Mitoxantrone—breast cancer	3.76e-05	0.000272	CcSEcCtD
Captopril—Nausea—Irinotecan—breast cancer	3.76e-05	0.000272	CcSEcCtD
Captopril—Constipation—Docetaxel—breast cancer	3.74e-05	0.00027	CcSEcCtD
Captopril—Dyspepsia—Capecitabine—breast cancer	3.73e-05	0.000269	CcSEcCtD
Captopril—Asthenia—Paclitaxel—breast cancer	3.71e-05	0.000268	CcSEcCtD
Captopril—Decreased appetite—Capecitabine—breast cancer	3.68e-05	0.000266	CcSEcCtD
Captopril—Alopecia—Epirubicin—breast cancer	3.67e-05	0.000265	CcSEcCtD
Captopril—Nausea—Gemcitabine—breast cancer	3.66e-05	0.000265	CcSEcCtD
Captopril—Fatigue—Capecitabine—breast cancer	3.65e-05	0.000264	CcSEcCtD
Captopril—Pruritus—Paclitaxel—breast cancer	3.65e-05	0.000264	CcSEcCtD
Captopril—Vision blurred—Methotrexate—breast cancer	3.64e-05	0.000263	CcSEcCtD
Captopril—Erythema multiforme—Doxorubicin—breast cancer	3.64e-05	0.000262	CcSEcCtD
Captopril—Constipation—Capecitabine—breast cancer	3.62e-05	0.000262	CcSEcCtD
Captopril—Feeling abnormal—Docetaxel—breast cancer	3.61e-05	0.00026	CcSEcCtD
Captopril—Nausea—Fluorouracil—breast cancer	3.6e-05	0.00026	CcSEcCtD
Captopril—Ill-defined disorder—Methotrexate—breast cancer	3.59e-05	0.000259	CcSEcCtD
Captopril—Gastrointestinal pain—Docetaxel—breast cancer	3.58e-05	0.000258	CcSEcCtD
Captopril—Anaemia—Methotrexate—breast cancer	3.57e-05	0.000258	CcSEcCtD
Captopril—Flushing—Doxorubicin—breast cancer	3.57e-05	0.000258	CcSEcCtD
Captopril—Tension—Epirubicin—breast cancer	3.55e-05	0.000256	CcSEcCtD
Captopril—Dysgeusia—Epirubicin—breast cancer	3.54e-05	0.000256	CcSEcCtD
Captopril—Diarrhoea—Paclitaxel—breast cancer	3.53e-05	0.000255	CcSEcCtD
Captopril—Nervousness—Epirubicin—breast cancer	3.51e-05	0.000254	CcSEcCtD
Captopril—Feeling abnormal—Capecitabine—breast cancer	3.49e-05	0.000252	CcSEcCtD
Captopril—Malaise—Methotrexate—breast cancer	3.49e-05	0.000252	CcSEcCtD
Captopril—Gastrointestinal pain—Capecitabine—breast cancer	3.47e-05	0.00025	CcSEcCtD
Captopril—Body temperature increased—Docetaxel—breast cancer	3.46e-05	0.00025	CcSEcCtD
Captopril—Abdominal pain—Docetaxel—breast cancer	3.46e-05	0.00025	CcSEcCtD
Captopril—Dizziness—Paclitaxel—breast cancer	3.41e-05	0.000247	CcSEcCtD
Captopril—Vision blurred—Epirubicin—breast cancer	3.41e-05	0.000246	CcSEcCtD
Captopril—Alopecia—Doxorubicin—breast cancer	3.4e-05	0.000245	CcSEcCtD
Captopril—Cough—Methotrexate—breast cancer	3.37e-05	0.000244	CcSEcCtD
Captopril—Ill-defined disorder—Epirubicin—breast cancer	3.36e-05	0.000242	CcSEcCtD
Captopril—Abdominal pain—Capecitabine—breast cancer	3.35e-05	0.000242	CcSEcCtD
Captopril—Body temperature increased—Capecitabine—breast cancer	3.35e-05	0.000242	CcSEcCtD
Captopril—Anaemia—Epirubicin—breast cancer	3.34e-05	0.000241	CcSEcCtD
Captopril—Chest pain—Methotrexate—breast cancer	3.29e-05	0.000238	CcSEcCtD
Captopril—Myalgia—Methotrexate—breast cancer	3.29e-05	0.000238	CcSEcCtD
Captopril—Arthralgia—Methotrexate—breast cancer	3.29e-05	0.000238	CcSEcCtD
Captopril—Tension—Doxorubicin—breast cancer	3.28e-05	0.000237	CcSEcCtD
Captopril—Vomiting—Paclitaxel—breast cancer	3.28e-05	0.000237	CcSEcCtD
Captopril—Dysgeusia—Doxorubicin—breast cancer	3.28e-05	0.000237	CcSEcCtD
Captopril—Malaise—Epirubicin—breast cancer	3.26e-05	0.000236	CcSEcCtD
Captopril—Rash—Paclitaxel—breast cancer	3.26e-05	0.000235	CcSEcCtD
Captopril—Dermatitis—Paclitaxel—breast cancer	3.25e-05	0.000235	CcSEcCtD
Captopril—Discomfort—Methotrexate—breast cancer	3.25e-05	0.000235	CcSEcCtD
Captopril—Nervousness—Doxorubicin—breast cancer	3.25e-05	0.000235	CcSEcCtD
Captopril—Syncope—Epirubicin—breast cancer	3.24e-05	0.000234	CcSEcCtD
Captopril—Headache—Paclitaxel—breast cancer	3.24e-05	0.000234	CcSEcCtD
Captopril—Palpitations—Epirubicin—breast cancer	3.2e-05	0.000231	CcSEcCtD
Captopril—Confusional state—Methotrexate—breast cancer	3.18e-05	0.00023	CcSEcCtD
Captopril—Loss of consciousness—Epirubicin—breast cancer	3.18e-05	0.00023	CcSEcCtD
Captopril—Cough—Epirubicin—breast cancer	3.16e-05	0.000228	CcSEcCtD
Captopril—Anaphylactic shock—Methotrexate—breast cancer	3.15e-05	0.000228	CcSEcCtD
Captopril—Vision blurred—Doxorubicin—breast cancer	3.15e-05	0.000228	CcSEcCtD
Captopril—Asthenia—Docetaxel—breast cancer	3.14e-05	0.000227	CcSEcCtD
Captopril—Ill-defined disorder—Doxorubicin—breast cancer	3.11e-05	0.000224	CcSEcCtD
Captopril—Pruritus—Docetaxel—breast cancer	3.1e-05	0.000224	CcSEcCtD
Captopril—Anaemia—Doxorubicin—breast cancer	3.09e-05	0.000223	CcSEcCtD
Captopril—Thrombocytopenia—Methotrexate—breast cancer	3.09e-05	0.000223	CcSEcCtD
Captopril—Arthralgia—Epirubicin—breast cancer	3.08e-05	0.000222	CcSEcCtD
Captopril—Chest pain—Epirubicin—breast cancer	3.08e-05	0.000222	CcSEcCtD
Captopril—Myalgia—Epirubicin—breast cancer	3.08e-05	0.000222	CcSEcCtD
Captopril—Nausea—Paclitaxel—breast cancer	3.07e-05	0.000221	CcSEcCtD
Captopril—Discomfort—Epirubicin—breast cancer	3.04e-05	0.00022	CcSEcCtD
Captopril—Asthenia—Capecitabine—breast cancer	3.04e-05	0.00022	CcSEcCtD
Captopril—Malaise—Doxorubicin—breast cancer	3.02e-05	0.000218	CcSEcCtD
Captopril—Dry mouth—Epirubicin—breast cancer	3.01e-05	0.000217	CcSEcCtD
Captopril—Anorexia—Methotrexate—breast cancer	3.01e-05	0.000217	CcSEcCtD
Captopril—Syncope—Doxorubicin—breast cancer	3e-05	0.000217	CcSEcCtD
Captopril—Pruritus—Capecitabine—breast cancer	3e-05	0.000216	CcSEcCtD
Captopril—Diarrhoea—Docetaxel—breast cancer	2.99e-05	0.000216	CcSEcCtD
Captopril—Confusional state—Epirubicin—breast cancer	2.98e-05	0.000215	CcSEcCtD
Captopril—Palpitations—Doxorubicin—breast cancer	2.96e-05	0.000214	CcSEcCtD
Captopril—Anaphylactic shock—Epirubicin—breast cancer	2.95e-05	0.000213	CcSEcCtD
Captopril—Hypotension—Methotrexate—breast cancer	2.95e-05	0.000213	CcSEcCtD
Captopril—Loss of consciousness—Doxorubicin—breast cancer	2.94e-05	0.000212	CcSEcCtD
Captopril—Cough—Doxorubicin—breast cancer	2.92e-05	0.000211	CcSEcCtD
Captopril—Shock—Epirubicin—breast cancer	2.9e-05	0.00021	CcSEcCtD
Captopril—Diarrhoea—Capecitabine—breast cancer	2.9e-05	0.000209	CcSEcCtD
Captopril—Dizziness—Docetaxel—breast cancer	2.89e-05	0.000209	CcSEcCtD
Captopril—Thrombocytopenia—Epirubicin—breast cancer	2.89e-05	0.000209	CcSEcCtD
Captopril—Tachycardia—Epirubicin—breast cancer	2.88e-05	0.000208	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methotrexate—breast cancer	2.87e-05	0.000208	CcSEcCtD
Captopril—Insomnia—Methotrexate—breast cancer	2.85e-05	0.000206	CcSEcCtD
Captopril—Chest pain—Doxorubicin—breast cancer	2.85e-05	0.000206	CcSEcCtD
Captopril—Arthralgia—Doxorubicin—breast cancer	2.85e-05	0.000206	CcSEcCtD
Captopril—Myalgia—Doxorubicin—breast cancer	2.85e-05	0.000206	CcSEcCtD
Captopril—Paraesthesia—Methotrexate—breast cancer	2.83e-05	0.000205	CcSEcCtD
Captopril—Discomfort—Doxorubicin—breast cancer	2.82e-05	0.000203	CcSEcCtD
Captopril—Anorexia—Epirubicin—breast cancer	2.81e-05	0.000203	CcSEcCtD
Captopril—Dyspnoea—Methotrexate—breast cancer	2.81e-05	0.000203	CcSEcCtD
Captopril—Somnolence—Methotrexate—breast cancer	2.8e-05	0.000202	CcSEcCtD
Captopril—Dizziness—Capecitabine—breast cancer	2.8e-05	0.000202	CcSEcCtD
Captopril—Dry mouth—Doxorubicin—breast cancer	2.79e-05	0.000201	CcSEcCtD
Captopril—Vomiting—Docetaxel—breast cancer	2.78e-05	0.000201	CcSEcCtD
Captopril—Dyspepsia—Methotrexate—breast cancer	2.78e-05	0.0002	CcSEcCtD
Captopril—Rash—Docetaxel—breast cancer	2.76e-05	0.000199	CcSEcCtD
Captopril—Hypotension—Epirubicin—breast cancer	2.76e-05	0.000199	CcSEcCtD
Captopril—Dermatitis—Docetaxel—breast cancer	2.76e-05	0.000199	CcSEcCtD
Captopril—Confusional state—Doxorubicin—breast cancer	2.75e-05	0.000199	CcSEcCtD
Captopril—Decreased appetite—Methotrexate—breast cancer	2.74e-05	0.000198	CcSEcCtD
Captopril—Headache—Docetaxel—breast cancer	2.74e-05	0.000198	CcSEcCtD
Captopril—Anaphylactic shock—Doxorubicin—breast cancer	2.73e-05	0.000197	CcSEcCtD
Captopril—Fatigue—Methotrexate—breast cancer	2.72e-05	0.000196	CcSEcCtD
Captopril—Vomiting—Capecitabine—breast cancer	2.69e-05	0.000195	CcSEcCtD
Captopril—Musculoskeletal discomfort—Epirubicin—breast cancer	2.69e-05	0.000194	CcSEcCtD
Captopril—Shock—Doxorubicin—breast cancer	2.69e-05	0.000194	CcSEcCtD
Captopril—Thrombocytopenia—Doxorubicin—breast cancer	2.67e-05	0.000193	CcSEcCtD
Captopril—Rash—Capecitabine—breast cancer	2.67e-05	0.000193	CcSEcCtD
Captopril—Insomnia—Epirubicin—breast cancer	2.67e-05	0.000193	CcSEcCtD
Captopril—Dermatitis—Capecitabine—breast cancer	2.67e-05	0.000193	CcSEcCtD
Captopril—Tachycardia—Doxorubicin—breast cancer	2.67e-05	0.000192	CcSEcCtD
Captopril—Headache—Capecitabine—breast cancer	2.65e-05	0.000192	CcSEcCtD
Captopril—Paraesthesia—Epirubicin—breast cancer	2.65e-05	0.000191	CcSEcCtD
Captopril—Dyspnoea—Epirubicin—breast cancer	2.63e-05	0.00019	CcSEcCtD
Captopril—Somnolence—Epirubicin—breast cancer	2.62e-05	0.000189	CcSEcCtD
Captopril—Anorexia—Doxorubicin—breast cancer	2.6e-05	0.000188	CcSEcCtD
Captopril—Nausea—Docetaxel—breast cancer	2.6e-05	0.000188	CcSEcCtD
Captopril—Feeling abnormal—Methotrexate—breast cancer	2.6e-05	0.000188	CcSEcCtD
Captopril—Dyspepsia—Epirubicin—breast cancer	2.6e-05	0.000188	CcSEcCtD
Captopril—Gastrointestinal pain—Methotrexate—breast cancer	2.58e-05	0.000186	CcSEcCtD
Captopril—Decreased appetite—Epirubicin—breast cancer	2.57e-05	0.000185	CcSEcCtD
Captopril—Hypotension—Doxorubicin—breast cancer	2.55e-05	0.000184	CcSEcCtD
Captopril—Fatigue—Epirubicin—breast cancer	2.55e-05	0.000184	CcSEcCtD
Captopril—Constipation—Epirubicin—breast cancer	2.52e-05	0.000182	CcSEcCtD
Captopril—Nausea—Capecitabine—breast cancer	2.52e-05	0.000182	CcSEcCtD
Captopril—Abdominal pain—Methotrexate—breast cancer	2.49e-05	0.00018	CcSEcCtD
Captopril—Body temperature increased—Methotrexate—breast cancer	2.49e-05	0.00018	CcSEcCtD
Captopril—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.49e-05	0.00018	CcSEcCtD
Captopril—Insomnia—Doxorubicin—breast cancer	2.47e-05	0.000178	CcSEcCtD
Captopril—Paraesthesia—Doxorubicin—breast cancer	2.45e-05	0.000177	CcSEcCtD
Captopril—Dyspnoea—Doxorubicin—breast cancer	2.44e-05	0.000176	CcSEcCtD
Captopril—Feeling abnormal—Epirubicin—breast cancer	2.43e-05	0.000176	CcSEcCtD
Captopril—Somnolence—Doxorubicin—breast cancer	2.43e-05	0.000175	CcSEcCtD
Captopril—Gastrointestinal pain—Epirubicin—breast cancer	2.41e-05	0.000174	CcSEcCtD
Captopril—Dyspepsia—Doxorubicin—breast cancer	2.4e-05	0.000174	CcSEcCtD
Captopril—Decreased appetite—Doxorubicin—breast cancer	2.37e-05	0.000171	CcSEcCtD
Captopril—Fatigue—Doxorubicin—breast cancer	2.36e-05	0.00017	CcSEcCtD
Captopril—Constipation—Doxorubicin—breast cancer	2.34e-05	0.000169	CcSEcCtD
Captopril—Abdominal pain—Epirubicin—breast cancer	2.33e-05	0.000169	CcSEcCtD
Captopril—Body temperature increased—Epirubicin—breast cancer	2.33e-05	0.000169	CcSEcCtD
Captopril—Asthenia—Methotrexate—breast cancer	2.26e-05	0.000163	CcSEcCtD
Captopril—Feeling abnormal—Doxorubicin—breast cancer	2.25e-05	0.000163	CcSEcCtD
Captopril—Gastrointestinal pain—Doxorubicin—breast cancer	2.23e-05	0.000161	CcSEcCtD
Captopril—Pruritus—Methotrexate—breast cancer	2.23e-05	0.000161	CcSEcCtD
Captopril—Body temperature increased—Doxorubicin—breast cancer	2.16e-05	0.000156	CcSEcCtD
Captopril—Abdominal pain—Doxorubicin—breast cancer	2.16e-05	0.000156	CcSEcCtD
Captopril—Diarrhoea—Methotrexate—breast cancer	2.16e-05	0.000156	CcSEcCtD
Captopril—Asthenia—Epirubicin—breast cancer	2.12e-05	0.000153	CcSEcCtD
Captopril—Pruritus—Epirubicin—breast cancer	2.09e-05	0.000151	CcSEcCtD
Captopril—Dizziness—Methotrexate—breast cancer	2.09e-05	0.000151	CcSEcCtD
Captopril—Diarrhoea—Epirubicin—breast cancer	2.02e-05	0.000146	CcSEcCtD
Captopril—Vomiting—Methotrexate—breast cancer	2.01e-05	0.000145	CcSEcCtD
Captopril—Rash—Methotrexate—breast cancer	1.99e-05	0.000144	CcSEcCtD
Captopril—Dermatitis—Methotrexate—breast cancer	1.99e-05	0.000143	CcSEcCtD
Captopril—Headache—Methotrexate—breast cancer	1.98e-05	0.000143	CcSEcCtD
Captopril—Asthenia—Doxorubicin—breast cancer	1.96e-05	0.000142	CcSEcCtD
Captopril—Dizziness—Epirubicin—breast cancer	1.95e-05	0.000141	CcSEcCtD
Captopril—Pruritus—Doxorubicin—breast cancer	1.93e-05	0.00014	CcSEcCtD
Captopril—Vomiting—Epirubicin—breast cancer	1.88e-05	0.000136	CcSEcCtD
Captopril—Nausea—Methotrexate—breast cancer	1.87e-05	0.000135	CcSEcCtD
Captopril—Diarrhoea—Doxorubicin—breast cancer	1.87e-05	0.000135	CcSEcCtD
Captopril—Rash—Epirubicin—breast cancer	1.86e-05	0.000134	CcSEcCtD
Captopril—Dermatitis—Epirubicin—breast cancer	1.86e-05	0.000134	CcSEcCtD
Captopril—Headache—Epirubicin—breast cancer	1.85e-05	0.000134	CcSEcCtD
Captopril—Dizziness—Doxorubicin—breast cancer	1.81e-05	0.00013	CcSEcCtD
Captopril—Nausea—Epirubicin—breast cancer	1.75e-05	0.000127	CcSEcCtD
Captopril—Vomiting—Doxorubicin—breast cancer	1.74e-05	0.000125	CcSEcCtD
Captopril—Rash—Doxorubicin—breast cancer	1.72e-05	0.000124	CcSEcCtD
Captopril—Dermatitis—Doxorubicin—breast cancer	1.72e-05	0.000124	CcSEcCtD
Captopril—Headache—Doxorubicin—breast cancer	1.71e-05	0.000124	CcSEcCtD
Captopril—Nausea—Doxorubicin—breast cancer	1.62e-05	0.000117	CcSEcCtD
Captopril—F2—Signaling Pathways—FN1—breast cancer	3.03e-06	2.35e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	3.03e-06	2.35e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HPGDS—breast cancer	3e-06	2.32e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NFKBIA—breast cancer	3e-06	2.32e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CD—breast cancer	2.99e-06	2.31e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HBA1—breast cancer	2.98e-06	2.31e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH1—breast cancer	2.97e-06	2.3e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MDM2—breast cancer	2.96e-06	2.29e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPINE1—breast cancer	2.95e-06	2.29e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RAF1—breast cancer	2.95e-06	2.28e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RELA—breast cancer	2.94e-06	2.27e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.93e-06	2.27e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—breast cancer	2.92e-06	2.26e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTT1—breast cancer	2.91e-06	2.25e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ACHE—breast cancer	2.91e-06	2.25e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CG—breast cancer	2.9e-06	2.25e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KIT—breast cancer	2.9e-06	2.25e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APC—breast cancer	2.9e-06	2.25e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MED12—breast cancer	2.88e-06	2.23e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—DPYD—breast cancer	2.88e-06	2.23e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MTOR—breast cancer	2.88e-06	2.23e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CB—breast cancer	2.88e-06	2.23e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGF—breast cancer	2.87e-06	2.22e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALDOA—breast cancer	2.84e-06	2.2e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS3—breast cancer	2.82e-06	2.18e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK3—breast cancer	2.78e-06	2.15e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—breast cancer	2.77e-06	2.14e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NCOA3—breast cancer	2.76e-06	2.14e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP17A1—breast cancer	2.76e-06	2.13e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A2—breast cancer	2.74e-06	2.12e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS1—breast cancer	2.73e-06	2.11e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ENO1—breast cancer	2.73e-06	2.11e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BRAF—breast cancer	2.73e-06	2.11e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MED12—breast cancer	2.72e-06	2.11e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—DPYD—breast cancer	2.72e-06	2.11e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.72e-06	2.11e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1B—breast cancer	2.7e-06	2.09e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CPT1A—breast cancer	2.68e-06	2.08e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ABCG2—breast cancer	2.68e-06	2.08e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTR—breast cancer	2.68e-06	2.08e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALDOA—breast cancer	2.68e-06	2.07e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2D6—breast cancer	2.68e-06	2.07e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—RAF1—breast cancer	2.67e-06	2.06e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1—breast cancer	2.66e-06	2.06e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT2—breast cancer	2.66e-06	2.06e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—breast cancer	2.65e-06	2.05e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—breast cancer	2.64e-06	2.05e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—breast cancer	2.64e-06	2.05e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HPGDS—breast cancer	2.63e-06	2.04e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NCOA2—breast cancer	2.63e-06	2.03e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HBA1—breast cancer	2.61e-06	2.02e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CB—breast cancer	2.6e-06	2.02e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NCOA3—breast cancer	2.6e-06	2.01e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A2—breast cancer	2.58e-06	2e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—breast cancer	2.58e-06	2e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JUN—breast cancer	2.57e-06	1.99e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CTNNB1—breast cancer	2.55e-06	1.98e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CD—breast cancer	2.55e-06	1.98e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTT1—breast cancer	2.55e-06	1.98e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ACHE—breast cancer	2.55e-06	1.98e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—FASN—breast cancer	2.55e-06	1.97e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—BCHE—breast cancer	2.54e-06	1.96e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CPT1A—breast cancer	2.53e-06	1.96e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTR—breast cancer	2.53e-06	1.96e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCG2—breast cancer	2.53e-06	1.96e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—breast cancer	2.53e-06	1.96e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SERPINE1—breast cancer	2.52e-06	1.95e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	2.51e-06	1.95e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC5A5—breast cancer	2.51e-06	1.94e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KRAS—breast cancer	2.5e-06	1.93e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1A—breast cancer	2.49e-06	1.93e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—breast cancer	2.49e-06	1.93e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HPGDS—breast cancer	2.48e-06	1.92e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.48e-06	1.92e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HBA1—breast cancer	2.46e-06	1.91e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK8—breast cancer	2.43e-06	1.89e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NQO1—breast cancer	2.42e-06	1.87e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC2A1—breast cancer	2.42e-06	1.87e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP17A1—breast cancer	2.41e-06	1.87e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOS3—breast cancer	2.41e-06	1.87e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ACHE—breast cancer	2.4e-06	1.86e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTT1—breast cancer	2.4e-06	1.86e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ENO1—breast cancer	2.39e-06	1.85e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS1—breast cancer	2.39e-06	1.85e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—breast cancer	2.39e-06	1.85e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.37e-06	1.83e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP3A4—breast cancer	2.36e-06	1.83e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.35e-06	1.82e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2D6—breast cancer	2.34e-06	1.82e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP1B1—breast cancer	2.32e-06	1.8e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SRC—breast cancer	2.31e-06	1.79e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	2.31e-06	1.79e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NCOA2—breast cancer	2.3e-06	1.78e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—breast cancer	2.29e-06	1.78e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MDM2—breast cancer	2.29e-06	1.77e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RAF1—breast cancer	2.28e-06	1.76e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP17A1—breast cancer	2.28e-06	1.76e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HSP90AA1—breast cancer	2.28e-06	1.76e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RELA—breast cancer	2.27e-06	1.76e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—breast cancer	2.25e-06	1.74e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS1—breast cancer	2.25e-06	1.74e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ENO1—breast cancer	2.25e-06	1.74e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—breast cancer	2.25e-06	1.74e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	2.24e-06	1.73e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—FASN—breast cancer	2.23e-06	1.73e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—breast cancer	2.23e-06	1.72e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CB—breast cancer	2.22e-06	1.72e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MTOR—breast cancer	2.22e-06	1.72e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BCHE—breast cancer	2.22e-06	1.72e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NCOA1—breast cancer	2.21e-06	1.71e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC5A5—breast cancer	2.2e-06	1.7e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—STK11—breast cancer	2.18e-06	1.69e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP19A1—breast cancer	2.18e-06	1.69e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NCOA2—breast cancer	2.17e-06	1.68e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—breast cancer	2.14e-06	1.65e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK3—breast cancer	2.13e-06	1.65e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—breast cancer	2.12e-06	1.64e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NQO1—breast cancer	2.12e-06	1.64e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A1—breast cancer	2.12e-06	1.64e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—FASN—breast cancer	2.1e-06	1.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BCHE—breast cancer	2.09e-06	1.62e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1B—breast cancer	2.09e-06	1.62e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SRC—breast cancer	2.09e-06	1.62e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC5A5—breast cancer	2.07e-06	1.6e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—breast cancer	2.07e-06	1.6e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP3A4—breast cancer	2.07e-06	1.6e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—breast cancer	2.06e-06	1.6e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—breast cancer	2.06e-06	1.6e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.05e-06	1.59e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—breast cancer	2.05e-06	1.58e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—breast cancer	2.04e-06	1.58e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP1B1—breast cancer	2.03e-06	1.57e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—breast cancer	2.03e-06	1.57e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—breast cancer	2.03e-06	1.57e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—COMT—breast cancer	2.03e-06	1.57e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—breast cancer	2.02e-06	1.57e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.02e-06	1.57e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTP1—breast cancer	2.02e-06	1.56e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A1—breast cancer	2e-06	1.55e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NQO1—breast cancer	2e-06	1.55e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HSP90AA1—breast cancer	1.99e-06	1.54e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—breast cancer	1.99e-06	1.54e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMOX1—breast cancer	1.99e-06	1.54e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JUN—breast cancer	1.99e-06	1.54e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ITPR1—breast cancer	1.99e-06	1.54e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNB1—breast cancer	1.97e-06	1.53e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP3A4—breast cancer	1.95e-06	1.51e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NCOA1—breast cancer	1.94e-06	1.5e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—breast cancer	1.93e-06	1.5e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1A—breast cancer	1.93e-06	1.49e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK3—breast cancer	1.92e-06	1.49e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—breast cancer	1.92e-06	1.49e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP1B1—breast cancer	1.92e-06	1.48e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—STK11—breast cancer	1.91e-06	1.48e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP19A1—breast cancer	1.91e-06	1.48e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KRAS—breast cancer	1.91e-06	1.48e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—breast cancer	1.91e-06	1.48e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK8—breast cancer	1.88e-06	1.46e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.88e-06	1.45e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—TYMS—breast cancer	1.88e-06	1.45e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—breast cancer	1.87e-06	1.45e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—breast cancer	1.86e-06	1.44e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PLA2G4A—breast cancer	1.85e-06	1.44e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTM1—breast cancer	1.85e-06	1.44e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NCOR1—breast cancer	1.85e-06	1.44e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NCOA1—breast cancer	1.83e-06	1.42e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—STK11—breast cancer	1.8e-06	1.39e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP19A1—breast cancer	1.8e-06	1.39e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SRC—breast cancer	1.78e-06	1.38e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—COMT—breast cancer	1.78e-06	1.38e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GPX1—breast cancer	1.78e-06	1.38e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTP1—breast cancer	1.77e-06	1.37e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP1A1—breast cancer	1.76e-06	1.36e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—breast cancer	1.76e-06	1.36e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMOX1—breast cancer	1.74e-06	1.35e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ERCC2—breast cancer	1.74e-06	1.35e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ITPR1—breast cancer	1.74e-06	1.35e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—breast cancer	1.74e-06	1.34e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—KRAS—breast cancer	1.73e-06	1.34e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—breast cancer	1.72e-06	1.33e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—breast cancer	1.7e-06	1.32e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—COMT—breast cancer	1.67e-06	1.3e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTP1—breast cancer	1.67e-06	1.29e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TYMS—breast cancer	1.64e-06	1.27e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMOX1—breast cancer	1.64e-06	1.27e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK3—breast cancer	1.64e-06	1.27e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ITPR1—breast cancer	1.64e-06	1.27e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTHFR—breast cancer	1.64e-06	1.27e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PLA2G4A—breast cancer	1.62e-06	1.26e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTM1—breast cancer	1.62e-06	1.26e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NCOR1—breast cancer	1.62e-06	1.26e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—breast cancer	1.62e-06	1.26e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—breast cancer	1.6e-06	1.24e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—breast cancer	1.59e-06	1.23e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—breast cancer	1.59e-06	1.23e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—breast cancer	1.58e-06	1.22e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—breast cancer	1.56e-06	1.21e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPX1—breast cancer	1.56e-06	1.21e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—breast cancer	1.55e-06	1.2e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TYMS—breast cancer	1.55e-06	1.2e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP1A1—breast cancer	1.54e-06	1.19e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—breast cancer	1.53e-06	1.19e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NCOR1—breast cancer	1.53e-06	1.19e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTM1—breast cancer	1.53e-06	1.19e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.53e-06	1.19e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ERCC2—breast cancer	1.53e-06	1.18e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CAV1—breast cancer	1.51e-06	1.17e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KRAS—breast cancer	1.48e-06	1.14e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—breast cancer	1.47e-06	1.14e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPX1—breast cancer	1.47e-06	1.14e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP1A1—breast cancer	1.45e-06	1.12e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.44e-06	1.12e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ERCC2—breast cancer	1.44e-06	1.11e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—breast cancer	1.44e-06	1.11e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—breast cancer	1.43e-06	1.11e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CG—breast cancer	1.38e-06	1.07e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—breast cancer	1.36e-06	1.05e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—breast cancer	1.35e-06	1.05e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CAV1—breast cancer	1.32e-06	1.03e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—breast cancer	1.31e-06	1.02e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—breast cancer	1.3e-06	1e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—breast cancer	1.25e-06	9.71e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CAV1—breast cancer	1.25e-06	9.67e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CD—breast cancer	1.21e-06	9.37e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CG—breast cancer	1.21e-06	9.34e-06	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—breast cancer	1.2e-06	9.3e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—NOS3—breast cancer	1.14e-06	8.85e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CG—breast cancer	1.14e-06	8.81e-06	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—breast cancer	1.11e-06	8.58e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CD—breast cancer	1.06e-06	8.21e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CB—breast cancer	1.06e-06	8.17e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—breast cancer	1.05e-06	8.11e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—breast cancer	1.05e-06	8.1e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NOS3—breast cancer	1e-06	7.76e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CD—breast cancer	1e-06	7.74e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—breast cancer	9.87e-07	7.64e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NOS3—breast cancer	9.44e-07	7.31e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CB—breast cancer	9.25e-07	7.16e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—breast cancer	9.16e-07	7.09e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—breast cancer	9.12e-07	7.06e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CB—breast cancer	8.71e-07	6.75e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—breast cancer	8.63e-07	6.69e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—breast cancer	7.99e-07	6.19e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—breast cancer	7.53e-07	5.83e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—breast cancer	6.43e-07	4.98e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—breast cancer	5.64e-07	4.36e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—breast cancer	5.31e-07	4.11e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—breast cancer	5.25e-07	4.07e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—breast cancer	4.6e-07	3.57e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—breast cancer	4.34e-07	3.36e-06	CbGpPWpGaD
